vs

Side-by-side financial comparison of UNIVERSAL TECHNICAL INSTITUTE INC (UTI) and Warby Parker Inc. (WRBY). Click either name above to swap in a different company.

UNIVERSAL TECHNICAL INSTITUTE INC is the larger business by last-quarter revenue ($220.8M vs $212.0M, roughly 1.0× Warby Parker Inc.). UNIVERSAL TECHNICAL INSTITUTE INC runs the higher net margin — 5.8% vs -2.8%, a 8.6% gap on every dollar of revenue. On growth, Warby Parker Inc. posted the faster year-over-year revenue change (11.2% vs 9.6%). Warby Parker Inc. produced more free cash flow last quarter ($8.1M vs $-19.2M). Over the past eight quarters, UNIVERSAL TECHNICAL INSTITUTE INC's revenue compounded faster (9.5% CAGR vs 2.9%).

Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.

Warby Parker Inc. is an American eyewear brand and retailer of prescription glasses, contact lenses, and sunglasses, based in New York City. It also offers eye exams. Originally founded in 2010 as an online-only retailer, the company now generates about two-thirds of its revenue from its 276 physical retail stores, 271 of which are in the U.S. and 5 of which are in Canada. The company intends to operate 900 stores. The company has 2.28 million customers; average order value is $263.

UTI vs WRBY — Head-to-Head

Bigger by revenue
UTI
UTI
1.0× larger
UTI
$220.8M
$212.0M
WRBY
Growing faster (revenue YoY)
WRBY
WRBY
+1.5% gap
WRBY
11.2%
9.6%
UTI
Higher net margin
UTI
UTI
8.6% more per $
UTI
5.8%
-2.8%
WRBY
More free cash flow
WRBY
WRBY
$27.3M more FCF
WRBY
$8.1M
$-19.2M
UTI
Faster 2-yr revenue CAGR
UTI
UTI
Annualised
UTI
9.5%
2.9%
WRBY

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
UTI
UTI
WRBY
WRBY
Revenue
$220.8M
$212.0M
Net Profit
$12.8M
$-6.0M
Gross Margin
52.4%
Operating Margin
7.1%
-3.2%
Net Margin
5.8%
-2.8%
Revenue YoY
9.6%
11.2%
Net Profit YoY
-42.1%
13.4%
EPS (diluted)
$0.23
$-0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
UTI
UTI
WRBY
WRBY
Q4 25
$220.8M
$212.0M
Q3 25
$222.4M
$221.7M
Q2 25
$204.3M
$214.5M
Q1 25
$207.4M
$223.8M
Q4 24
$201.4M
$190.6M
Q3 24
$196.4M
$192.4M
Q2 24
$177.5M
$188.2M
Q1 24
$184.2M
$200.0M
Net Profit
UTI
UTI
WRBY
WRBY
Q4 25
$12.8M
$-6.0M
Q3 25
$18.8M
$5.9M
Q2 25
$10.7M
$-1.8M
Q1 25
$11.4M
$3.5M
Q4 24
$22.2M
$-6.9M
Q3 24
$18.8M
$-4.1M
Q2 24
$5.0M
$-6.8M
Q1 24
$7.8M
$-2.7M
Gross Margin
UTI
UTI
WRBY
WRBY
Q4 25
52.4%
Q3 25
54.1%
Q2 25
53.0%
Q1 25
56.3%
Q4 24
54.1%
Q3 24
54.5%
Q2 24
56.0%
Q1 24
56.7%
Operating Margin
UTI
UTI
WRBY
WRBY
Q4 25
7.1%
-3.2%
Q3 25
11.2%
1.6%
Q2 25
6.9%
-2.1%
Q1 25
8.1%
1.1%
Q4 24
13.6%
-4.9%
Q3 24
13.3%
-3.4%
Q2 24
4.2%
-4.8%
Q1 24
6.1%
-2.6%
Net Margin
UTI
UTI
WRBY
WRBY
Q4 25
5.8%
-2.8%
Q3 25
8.4%
2.6%
Q2 25
5.2%
-0.8%
Q1 25
5.5%
1.6%
Q4 24
11.0%
-3.6%
Q3 24
9.6%
-2.1%
Q2 24
2.8%
-3.6%
Q1 24
4.2%
-1.3%
EPS (diluted)
UTI
UTI
WRBY
WRBY
Q4 25
$0.23
$-0.06
Q3 25
$0.33
$0.05
Q2 25
$0.19
$-0.01
Q1 25
$0.21
$0.03
Q4 24
$0.40
$-0.06
Q3 24
$0.35
$-0.03
Q2 24
$0.09
$-0.06
Q1 24
$0.14
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
UTI
UTI
WRBY
WRBY
Cash + ST InvestmentsLiquidity on hand
$162.8M
$286.4M
Total DebtLower is stronger
$101.4M
Stockholders' EquityBook value
$335.9M
$367.7M
Total Assets
$834.0M
$720.9M
Debt / EquityLower = less leverage
0.30×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
UTI
UTI
WRBY
WRBY
Q4 25
$162.8M
$286.4M
Q3 25
$169.1M
$280.4M
Q2 25
$70.7M
$286.4M
Q1 25
$96.0M
$265.1M
Q4 24
$172.0M
$254.2M
Q3 24
$161.9M
$251.0M
Q2 24
$115.5M
$238.0M
Q1 24
$116.1M
$220.4M
Total Debt
UTI
UTI
WRBY
WRBY
Q4 25
$101.4M
Q3 25
$87.1M
Q2 25
$73.8M
Q1 25
$94.4M
Q4 24
$120.1M
Q3 24
$125.7M
Q2 24
$137.3M
Q1 24
$141.9M
Stockholders' Equity
UTI
UTI
WRBY
WRBY
Q4 25
$335.9M
$367.7M
Q3 25
$328.1M
$369.6M
Q2 25
$306.8M
$361.5M
Q1 25
$293.9M
$354.1M
Q4 24
$280.0M
$340.1M
Q3 24
$260.2M
$336.8M
Q2 24
$239.4M
$329.4M
Q1 24
$232.6M
$316.2M
Total Assets
UTI
UTI
WRBY
WRBY
Q4 25
$834.0M
$720.9M
Q3 25
$826.1M
$706.9M
Q2 25
$740.8M
$701.9M
Q1 25
$720.4M
$682.8M
Q4 24
$753.8M
$676.5M
Q3 24
$744.6M
$638.0M
Q2 24
$706.0M
$618.2M
Q1 24
$702.1M
$592.9M
Debt / Equity
UTI
UTI
WRBY
WRBY
Q4 25
0.30×
Q3 25
0.27×
Q2 25
0.24×
Q1 25
0.32×
Q4 24
0.43×
Q3 24
0.48×
Q2 24
0.57×
Q1 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
UTI
UTI
WRBY
WRBY
Operating Cash FlowLast quarter
$3.1M
$23.3M
Free Cash FlowOCF − Capex
$-19.2M
$8.1M
FCF MarginFCF / Revenue
-8.7%
3.8%
Capex IntensityCapex / Revenue
10.1%
7.1%
Cash ConversionOCF / Net Profit
0.24×
TTM Free Cash FlowTrailing 4 quarters
$16.6M
$43.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
UTI
UTI
WRBY
WRBY
Q4 25
$3.1M
$23.3M
Q3 25
$57.1M
$18.0M
Q2 25
$18.1M
$40.2M
Q1 25
$-789.0K
$29.4M
Q4 24
$23.0M
$19.9M
Q3 24
$67.5M
$27.3M
Q2 24
$10.0M
$31.6M
Q1 24
$-2.5M
$19.9M
Free Cash Flow
UTI
UTI
WRBY
WRBY
Q4 25
$-19.2M
$8.1M
Q3 25
$40.6M
$-1.5M
Q2 25
$6.8M
$23.9M
Q1 25
$-11.7M
$13.2M
Q4 24
$19.6M
$2.2M
Q3 24
$60.0M
$13.1M
Q2 24
$3.0M
$14.0M
Q1 24
$-8.4M
$5.5M
FCF Margin
UTI
UTI
WRBY
WRBY
Q4 25
-8.7%
3.8%
Q3 25
18.3%
-0.7%
Q2 25
3.4%
11.1%
Q1 25
-5.7%
5.9%
Q4 24
9.7%
1.1%
Q3 24
30.6%
6.8%
Q2 24
1.7%
7.4%
Q1 24
-4.6%
2.7%
Capex Intensity
UTI
UTI
WRBY
WRBY
Q4 25
10.1%
7.1%
Q3 25
7.4%
8.8%
Q2 25
5.5%
7.6%
Q1 25
5.3%
7.2%
Q4 24
1.7%
9.3%
Q3 24
3.8%
7.4%
Q2 24
4.0%
9.4%
Q1 24
3.2%
7.2%
Cash Conversion
UTI
UTI
WRBY
WRBY
Q4 25
0.24×
Q3 25
3.04×
3.06×
Q2 25
1.69×
Q1 25
-0.07×
8.46×
Q4 24
1.04×
Q3 24
3.58×
Q2 24
2.01×
Q1 24
-0.32×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

UTI
UTI

UTI$142.8M65%
Concorde$78.0M35%

WRBY
WRBY

Retail$155.2M73%
E Commerce$56.8M27%

Related Comparisons